142 related articles for article (PubMed ID: 34590497)
1. The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.
Abdel-Razeq H; Ma'koseh M; Mansour A; Bater R; Amarin R; Abufara A; Halahleh K; Manassra M; Alrwashdeh M; Almomani M; Zmaily M
Clin Appl Thromb Hemost; 2021; 27():10760296211045908. PubMed ID: 34590497
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice.
Rupa-Matysek J; Brzeźniakiewicz-Janus K; Gil L; Krasiński Z; Komarnicki M
Cancer Med; 2018 Jul; 7(7):2868-2875. PubMed ID: 29761831
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional Study of Patients with Diffuse Large B-Cell Lymphoma: Assessing the Effect of Host Status, Tumor Burden, and Inflammatory Activity on Venous Thromboembolism.
Lim SH; Woo SY; Kim S; Ko YH; Kim WS; Kim SJ
Cancer Res Treat; 2016 Jan; 48(1):312-21. PubMed ID: 25761485
[TBL] [Abstract][Full Text] [Related]
4. Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma.
Rupa-Matysek J; Gil L; Kroll-Balcerzak R; Barańska M; Komarnicki M
Hematol Oncol; 2017 Dec; 35(4):456-464. PubMed ID: 27377517
[TBL] [Abstract][Full Text] [Related]
5. Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma.
Hantrakun N; Phinyo P; Tantiworawit A; Rattarittamrong E; Chai-Adisaksopha C; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Niprapan P; Norasetthada L
J Thromb Thrombolysis; 2024 Mar; 57(3):473-482. PubMed ID: 38091158
[TBL] [Abstract][Full Text] [Related]
6. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
[TBL] [Abstract][Full Text] [Related]
7. The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma.
Kirkizlar O; Alp Kirkizlar T; Umit EG; Asker I; Baysal M; Bas V; Gulsaran SK; Demirci U; Demir AM
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):542-547. PubMed ID: 32245743
[TBL] [Abstract][Full Text] [Related]
8. Incidence of venous thromboembolism in patients with diffuse large B-cell lymphoma.
Borg IH; Bendtsen MD; Bøgsted M; Madsen J; Severinsen MT
Leuk Lymphoma; 2016 Dec; 57(12):2771-2776. PubMed ID: 27266904
[TBL] [Abstract][Full Text] [Related]
9. Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
Gangaraju R; Davis ES; Bhatia S; Kenzik KM
Cancer; 2022 Jun; 128(12):2348-2357. PubMed ID: 35363373
[TBL] [Abstract][Full Text] [Related]
10. Incidence of venous thromboembolism in patients with non-Hodgkin lymphoma.
Sanfilippo KM; Wang TF; Gage BF; Luo S; Riedell P; Carson KR
Thromb Res; 2016 Jul; 143():86-90. PubMed ID: 27208462
[TBL] [Abstract][Full Text] [Related]
11. Mean platelet volume as a predictive marker for venous thromboembolism in patients treated for Hodgkin lymphoma.
Rupa-Matysek J; Gil L; Barańska M; Dytfeld D; Komarnicki M
Oncotarget; 2018 Apr; 9(30):21190-21200. PubMed ID: 29765530
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for developing venous thromboembolism in Japanese with diffuse large b-cell lymphoma.
Yokoyama K; Murata M; Ikeda Y; Okamoto S
Thromb Res; 2012 Jul; 130(1):7-11. PubMed ID: 22000981
[TBL] [Abstract][Full Text] [Related]
13. Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction models.
Dharmavaram G; Cao S; Sundaram S; Ayyappan S; Boughan K; Gallogly M; Malek E; Metheny L; Tomlinson B; Otegbeye F; Lazarus HM; Cooper B; Fu P; de Lima M; Caimi PF
Am J Hematol; 2020 Aug; 95(8):918-926. PubMed ID: 32311162
[TBL] [Abstract][Full Text] [Related]
14. The Application of Existing Risk Assessment Models (RAMS) to Predict the Occurrence of Venous Thromboembolic Events among Patients with Classic Hodgkin Lymphoma.
Ma'koseh M; Abufara A; Albaghdadi D; Ghalayni R; Abdel-Razeq S; Alzughali E; Abdel Rahman F; Alhalaseh Y; Halahleh K; Abdel-Razeq H
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256570
[No Abstract] [Full Text] [Related]
15. The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients.
Abdel-Razeq H; Ma'koseh M; Abdel-Razeq R; Amarin R; Abufara A; Mansour R; Manasrah M; Al-Rwashdeh M; Bater R
Front Oncol; 2021; 11():677776. PubMed ID: 34123847
[TBL] [Abstract][Full Text] [Related]
16. Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma.
Bastos-Oreiro M; Ortiz J; Pradillo V; Salas E; Marínez-Laperche C; Muñoz A; Buño I; Diéz-Martin JL; Soria JM; Pascual Izquierdo C
Cancer Med; 2021 Nov; 10(21):7585-7592. PubMed ID: 34598309
[TBL] [Abstract][Full Text] [Related]
17. COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
Abdel-Razeq H; Sharaf B; Al-Jaghbeer MJ; Abu-Fares H; Bater R; Shaer MA; Abu-Jaish H; Laban DA; Salamah O; Tamimi F; Ashouri K; Salameh T; Zughul R; Alhalaseh Y
J Thromb Thrombolysis; 2023 Oct; 56(3):447-453. PubMed ID: 37430158
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Patterns, and Predictors of Venous Thromboembolic Events in Patients Undergoing Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Lymphomas.
Ma'koseh M; Alrwashdeh M; Abdel-Razeq N; Alfar R; Edaily S; Bater R; Zmaily M; Almomani M; Abdel-Razeq H
Hematol Oncol Stem Cell Ther; 2023 May; 16(4):323-329. PubMed ID: 37363978
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in patients with diffuse large B-cell lymphoma.
Komrokji RS; Uppal NP; Khorana AA; Lyman GH; Kaplan KL; Fisher RI; Francis CW
Leuk Lymphoma; 2006 Jun; 47(6):1029-33. PubMed ID: 16840193
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
